chrX-101616200-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000361910.9(ARMCX6):c.421G>A(p.Glu141Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000829 in 1,206,082 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000361910.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARMCX6 | NM_019007.4 | c.421G>A | p.Glu141Lys | missense_variant | 3/3 | ENST00000361910.9 | NP_061880.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARMCX6 | ENST00000361910.9 | c.421G>A | p.Glu141Lys | missense_variant | 3/3 | 1 | NM_019007.4 | ENSP00000354708 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000185 AC: 2AN: 107840Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 30212
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 182819Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67675
GnomAD4 exome AF: 0.00000728 AC: 8AN: 1098242Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 2AN XY: 363596
GnomAD4 genome AF: 0.0000185 AC: 2AN: 107840Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 30212
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2022 | The c.421G>A (p.E141K) alteration is located in exon 4 (coding exon 1) of the ARMCX6 gene. This alteration results from a G to A substitution at nucleotide position 421, causing the glutamic acid (E) at amino acid position 141 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at